Loading insider details...
Latest Form 4 (Aug 25, 2026): Sale of 29,697 ALLO shares, $63.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 25, 2026 | Allogene Therapeutics, Inc. (ALLO) | Sale | 29,697 | $63.0K |
| Feb 4, 2026 | Allogene Therapeutics, Inc. (ALLO) | Sale | 22,900 | $40.3K |
| Feb 5, 2025 | Allogene Therapeutics, Inc. (ALLO) | Sale | 6,404 | $11.0K |
| Jan 29, 2025 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 144,928 | n/a |
| Aug 23, 2024 | Allogene Therapeutics, Inc. (ALLO) | Tax Withholding | 28,310 | $78.8K |
| Jan 31, 2024 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 41,800 | n/a |
| Aug 17, 2023 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 108,958 | n/a |